Jihui Hao Selected Research

Doxycycline (Periostat)

12/2019

The mitochondrial deoxyguanosine kinase is required for cancer cell stemness in lung adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jihui Hao Research Topics

Disease

59	Neoplasms (Cancer) 05/2024 - 04/2007
40	Pancreatic Neoplasms (Pancreatic Cancer) 03/2024 - 06/2010
28	Adenocarcinoma 01/2024 - 01/2012
14	Hypoxia (Hypoxemia) 10/2023 - 09/2011
13	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2014
4	Breast Neoplasms (Breast Cancer) 01/2024 - 03/2010
3	Lung Neoplasms (Lung Cancer) 10/2021 - 10/2019
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2024 - 10/2023
2	Liver Neoplasms (Liver Cancer) 11/2022 - 09/2015
2	Fibrosis (Cirrhosis) 11/2022 - 02/2016
2	Carcinogenesis 01/2022 - 01/2017
2	Hepatocellular Carcinoma (Hepatoma) 01/2017 - 10/2014
1	Rare Diseases (Rare Disease) 10/2023
1	Neuroendocrine Carcinoma 10/2023
1	Neoplasms, Cystic, Mucinous, and Serous 11/2022
1	Embolism (Embolus) 01/2022
1	Genomic Instability 01/2022
1	Carcinoma (Carcinomatosis) 10/2021
1	Malnutrition (Nutritional Deficiencies) 01/2021
1	Muscular Atrophy (Muscle Atrophy) 01/2021
1	Atrophy 01/2021

Drug/Important Bio-Agent (IBA)

19	Gemcitabine FDA Link 01/2024 - 02/2015
14	Proteins (Proteins, Gene)FDA Link 10/2023 - 06/2010
8	Biomarkers (Surrogate Marker)IBA 10/2023 - 10/2014
7	ChromatinIBA 11/2022 - 01/2012
7	Messenger RNA (mRNA)IBA 01/2021 - 04/2007
4	LuciferasesIBA 11/2022 - 01/2012
4	AntigensIBA 11/2022 - 03/2014
4	fascinIBA 10/2021 - 05/2014
3	InterleukinsIBA 01/2024 - 01/2017
3	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 11/2013
3	IronIBA 05/2023 - 01/2019
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2023 - 01/2019
3	LipidsIBA 01/2022 - 04/2015
3	Small Interfering RNA (siRNA)IBA 01/2022 - 04/2015
3	2- amino- 3- (4'- N,N- bis(2- chloroethyl)amino)phenylpropionic acid N-oxideIBA 09/2019 - 02/2015
3	Liposomes (Liposome)IBA 01/2019 - 02/2016
3	Stem Cell FactorIBA 01/2017 - 10/2014
3	Transcription Factors (Transcription Factor)IBA 10/2016 - 09/2011
2	Chemokine ReceptorsIBA 03/2024 - 01/2012
2	Neutralizing AntibodiesIBA 01/2024 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2024 - 01/2023
2	Indicators and Reagents (Reagents)IBA 01/2024 - 12/2021
2	Oxygen (Dioxygen)IBA 10/2023 - 01/2019
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2023 - 04/2013
2	Pregnenolone Carbonitrile (PCN)IBA 11/2022 - 02/2018
2	CarbohydratesIBA 11/2022 - 02/2018
2	RNA (Ribonucleic Acid)IBA 02/2022 - 01/2015
2	Albumin-Bound Paclitaxel FDA Link 01/2022 - 06/2021
2	PolymersIBA 01/2022 - 04/2015
2	CollagenIBA 01/2021 - 02/2016
2	Deferoxamine (Desferal)FDA LinkGeneric 01/2020 - 01/2019
2	Chelating AgentsIBA 01/2020 - 01/2019
2	pirfenidoneIBA 01/2017 - 02/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2015 - 03/2015
2	HydrogelsIBA 03/2015 - 01/2015
2	LeptinIBA 11/2014 - 03/2010
1	NifurtimoxIBA 03/2024
1	glucose-regulated proteinsIBA 10/2023
1	Endoplasmic Reticulum Chaperone BiPIBA 10/2023
1	RNA Splicing FactorsIBA 10/2023
1	Focal Adhesion Protein-Tyrosine KinasesIBA 10/2023
1	Serine (L-Serine)FDA Link 10/2023
1	Arginine (L-Arginine)FDA Link 10/2023
1	Irbesartan FDA LinkGeneric 05/2023
1	nucleotidaseIBA 01/2023
1	Diclofenac (SR 38)FDA LinkGeneric 01/2023
1	Monoclonal AntibodiesIBA 01/2023
1	Methionine (L-Methionine)FDA Link 11/2022
1	NitrosaminesIBA 11/2022
1	Hemoglobins (Hemoglobin)IBA 11/2022
1	Colchicine FDA LinkGeneric 11/2022
1	Carcinoembryonic AntigenIBA 11/2022
1	HeterochromatinIBA 02/2022
1	EuchromatinIBA 02/2022
1	CalciumIBA 01/2022
1	Cystine (L-Cystine)IBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Fibrinogen (Factor I)FDA Link 01/2022
1	Biocompatible Materials (Biomaterials)IBA 01/2022
1	AntioxidantsIBA 01/2022
1	Rosiglitazone (Avandia)FDA Link 01/2022
1	7- methyl- 5- (1- ((3- (trifluoromethyl)phenyl)acetyl)- 2,3- dihydro- 1H- indol- 5- yl)- 7H- pyrrolo(2,3- d)pyrimidin- 4- amineIBA 01/2022
1	Tumor Biomarkers (Tumor Markers)IBA 01/2022
1	mitochondrial calcium uniporterIBA 01/2022
1	ClaudinsIBA 01/2022
1	folfirinoxIBA 06/2021
1	Insulin-Like Growth Factor Binding Protein 2IBA 01/2021
1	oil red OIBA 01/2021
1	PlasticsIBA 01/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2021
1	AntibodiesIBA 01/2020
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2020

Therapy/Procedure

11	Therapeutics 01/2023 - 06/2010
9	Drug Therapy (Chemotherapy) 03/2024 - 01/2012
6	Immunotherapy 05/2024 - 01/2016
2	Pancreaticoduodenectomy 07/2023 - 10/2015
1	Neoadjuvant Therapy 06/2023
1	Adjuvant Chemotherapy 01/2022
1	Nutrition Therapy (Medical Nutrition Therapy) 01/2021